000			01967 a2200529 4500
005			20250515091206.0
264		0	_c20080416
008			200804s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdm460 _2doi
040			_aNLM _beng _cNLM
100	1		_aMir, O
245	0	0	_aEmerging therapeutic options for breast cancer chemotherapy during pregnancy. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cApr 2008
300			_a607-13 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aDocetaxel
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLapatinib
650	0	4	_aOligohydramnios _xchemically induced
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aPregnancy
650	0	4	_aPregnancy Complications, Neoplastic _xdrug therapy
650	0	4	_aPregnancy Trimester, Second
650	0	4	_aPregnancy Trimester, Third
650	0	4	_aQuinazolines _xadministration & dosage
650	0	4	_aReceptor, ErbB-2 _xdrug effects
650	0	4	_aTaxoids _xadministration & dosage
650	0	4	_aTrastuzumab
650	0	4	_aVinblastine _xadministration & dosage
650	0	4	_aVinorelbine
700	1		_aBerveiller, P
700	1		_aRopert, S
700	1		_aGoffinet, F
700	1		_aPons, G
700	1		_aTreluyer, J-M
700	1		_aGoldwasser, F
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 19 _gno. 4 _gp. 607-13
856	4	0	_uhttps://doi.org/10.1093/annonc/mdm460 _zAvailable from publisher's website
999			_c17442523 _d17442523